375 related articles for article (PubMed ID: 29031411)
1. In Vivo Brain Glycine and Glutamate Concentrations in Patients With First-Episode Psychosis Measured by Echo Time-Averaged Proton Magnetic Resonance Spectroscopy at 4T.
Kim SY; Kaufman MJ; Cohen BM; Jensen JE; Coyle JT; Du F; Öngür D
Biol Psychiatry; 2018 Mar; 83(6):484-491. PubMed ID: 29031411
[TBL] [Abstract][Full Text] [Related]
2. Anterior Cingulate Cortex Glutamatergic Metabolites and Mood Stabilizers in Euthymic Bipolar I Disorder Patients: A Proton Magnetic Resonance Spectroscopy Study.
Soeiro-de-Souza MG; Otaduy MCG; Machado-Vieira R; Moreno RA; Nery FG; Leite C; Lafer B
Biol Psychiatry Cogn Neurosci Neuroimaging; 2018 Dec; 3(12):985-991. PubMed ID: 29789269
[TBL] [Abstract][Full Text] [Related]
3. Brain metabolite alterations in young adults at familial high risk for schizophrenia using proton magnetic resonance spectroscopy.
Tandon N; Bolo NR; Sanghavi K; Mathew IT; Francis AN; Stanley JA; Keshavan MS
Schizophr Res; 2013 Aug; 148(1-3):59-66. PubMed ID: 23791389
[TBL] [Abstract][Full Text] [Related]
4. Functional magnetic resonance spectroscopy in patients with schizophrenia and bipolar affective disorder: Glutamate dynamics in the anterior cingulate cortex during a working memory task.
Jelen LA; King S; Horne CM; Lythgoe DJ; Young AH; Stone JM
Eur Neuropsychopharmacol; 2019 Dec; 29(2):222-234. PubMed ID: 30558824
[TBL] [Abstract][Full Text] [Related]
5. Elevated Myo-Inositol, Choline, and Glutamate Levels in the Associative Striatum of Antipsychotic-Naive Patients With First-Episode Psychosis: A Proton Magnetic Resonance Spectroscopy Study With Implications for Glial Dysfunction.
Plitman E; de la Fuente-Sandoval C; Reyes-Madrigal F; Chavez S; Gómez-Cruz G; León-Ortiz P; Graff-Guerrero A
Schizophr Bull; 2016 Mar; 42(2):415-24. PubMed ID: 26320195
[TBL] [Abstract][Full Text] [Related]
6. Effects of repeated dizocilpine treatment on glutamatergic activity in the prefrontal cortex in an animal model of schizophrenia: An in vivo proton magnetic resonance spectroscopy study at 9.4T.
Yoo CH; Song KH; Lim SI; Lee DW; Woo DC; Choe BY
Neurosci Lett; 2017 Jan; 637():57-63. PubMed ID: 27894920
[TBL] [Abstract][Full Text] [Related]
7. The association between
Beck K; Arumuham A; Brugger S; McCutcheon RA; Veronese M; Santangelo B; McGinnity CJ; Dunn J; Kaar S; Singh N; Pillinger T; Borgan F; Sementa T; Neji R; Jauhar S; Aigbirhio F; Boros I; Turkheimer F; Hammers A; Lythgoe D; Stone J; Howes OD
J Psychopharmacol; 2022 Sep; 36(9):1051-1060. PubMed ID: 36120998
[TBL] [Abstract][Full Text] [Related]
8. In vivo gamma-aminobutyric acid and glutamate levels in people with first-episode schizophrenia: A proton magnetic resonance spectroscopy study.
Chiu PW; Lui SSY; Hung KSY; Chan RCK; Chan Q; Sham PC; Cheung EFC; Mak HKF
Schizophr Res; 2018 Mar; 193():295-303. PubMed ID: 28751130
[TBL] [Abstract][Full Text] [Related]
9. 1H-magnetic resonance spectroscopy study of glutamate-related abnormality in bipolar disorder.
Kubo H; Nakataki M; Sumitani S; Iga JI; Numata S; Kameoka N; Watanabe SY; Umehara H; Kinoshita M; Inoshita M; Tamaru M; Ohta M; Nakayama-Yamauchi C; Funakoshi Y; Harada M; Ohmori T
J Affect Disord; 2017 Jan; 208():139-144. PubMed ID: 27770643
[TBL] [Abstract][Full Text] [Related]
10. Assessing Brain Metabolism With 7-T Proton Magnetic Resonance Spectroscopy in Patients With First-Episode Psychosis.
Wang AM; Pradhan S; Coughlin JM; Trivedi A; DuBois SL; Crawford JL; Sedlak TW; Nucifora FC; Nestadt G; Nucifora LG; Schretlen DJ; Sawa A; Barker PB
JAMA Psychiatry; 2019 Mar; 76(3):314-323. PubMed ID: 30624573
[TBL] [Abstract][Full Text] [Related]
11. Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level: A Mega-analysis of Individual Participant-Level Data.
Merritt K; McGuire PK; Egerton A; ; Aleman A; Block W; Bloemen OJN; Borgan F; Bustillo JR; Capizzano AA; Coughlin JM; De la Fuente-Sandoval C; Demjaha A; Dempster K; Do KQ; Du F; Falkai P; Galinska-Skok B; Gallinat J; Gasparovic C; Ginestet CE; Goto N; Graff-Guerrero A; Ho BC; Howes OD; Jauhar S; Jeon P; Kato T; Kaufmann CA; Kegeles LS; Keshavan M; Kim SY; Kunugi H; Lauriello J; Liemburg EJ; Mcilwain ME; Modinos G; Mouchlianitis ED; Nakamura J; Nenadic I; Öngür D; Ota M; Palaniyappan L; Pantelis C; Plitman E; Posporelis S; Purdon SE; Reichenbach JR; Renshaw PF; Russell BR; Sawa A; Schaefer M; Shungu DC; Smesny S; Stanley JA; Stone JM; Szulc A; Taylor R; Thakkar K; Théberge J; Tibbo PG; van Amelsvoort T; Walecki J; Williamson PC; Wood SJ; Xin L; Yamasue H
JAMA Psychiatry; 2021 Jun; 78(6):667-681. PubMed ID: 33881460
[TBL] [Abstract][Full Text] [Related]
12. Cortico-Striatal GABAergic and Glutamatergic Dysregulations in Subjects at Ultra-High Risk for Psychosis Investigated with Proton Magnetic Resonance Spectroscopy.
de la Fuente-Sandoval C; Reyes-Madrigal F; Mao X; León-Ortiz P; Rodríguez-Mayoral O; Solís-Vivanco R; Favila R; Graff-Guerrero A; Shungu DC
Int J Neuropsychopharmacol; 2015 Sep; 19(3):pyv105. PubMed ID: 26364273
[TBL] [Abstract][Full Text] [Related]
13. Associations of hippocampal metabolism and regional brain grey matter in neuroleptic-naïve ultra-high-risk subjects and first-episode schizophrenia.
Nenadic I; Maitra R; Basu S; Dietzek M; Schönfeld N; Lorenz C; Gussew A; Amminger GP; McGorry P; Reichenbach JR; Sauer H; Gaser C; Smesny S
Eur Neuropsychopharmacol; 2015 Oct; 25(10):1661-8. PubMed ID: 26088723
[TBL] [Abstract][Full Text] [Related]
14. Glutamatergic dysfunction linked to energy and membrane lipid metabolism in frontal and anterior cingulate cortices of never treated first-episode schizophrenia patients.
Smesny S; Gussew A; Biesel NJ; Schack S; Walther M; Rzanny R; Milleit B; Gaser C; Sobanski T; Schultz CC; Amminger P; Hipler UC; Sauer H; Reichenbach JR
Schizophr Res; 2015 Oct; 168(1-2):322-9. PubMed ID: 26255566
[TBL] [Abstract][Full Text] [Related]
15. Abnormal glutamatergic neurotransmission and neuronal-glial interactions in acute mania.
Öngür D; Jensen JE; Prescot AP; Stork C; Lundy M; Cohen BM; Renshaw PF
Biol Psychiatry; 2008 Oct; 64(8):718-726. PubMed ID: 18602089
[TBL] [Abstract][Full Text] [Related]
16. Hippocampal glutamatergic/NMDA receptor functioning in bipolar disorder: A study combining mismatch negativity and proton magnetic resonance spectroscopy.
Chitty KM; Lagopoulos J; Hickie IB; Hermens DF
Psychiatry Res; 2015 Aug; 233(2):88-94. PubMed ID: 26070970
[TBL] [Abstract][Full Text] [Related]
17. Investigation of Heschl's gyrus and planum temporale in patients with schizophrenia and bipolar disorder: a proton magnetic resonance spectroscopy study.
Atagün MI; Şıkoğlu EM; Can SS; Karakaş-Uğurlu G; Ulusoy-Kaymak S; Çayköylü A; Algın O; Phillips ML; Moore CM; Öngür D
Schizophr Res; 2015 Feb; 161(2-3):202-9. PubMed ID: 25480359
[TBL] [Abstract][Full Text] [Related]
18. Brain glutamate concentration in men with early psychosis: a magnetic resonance spectroscopy case-control study at 7 T.
Godlewska BR; Minichino A; Emir U; Angelescu I; Lennox B; Micunovic M; Howes O; Cowen PJ
Transl Psychiatry; 2021 Jun; 11(1):367. PubMed ID: 34226485
[TBL] [Abstract][Full Text] [Related]
19. Anterior cingulate Glutamate-Glutamine cycle metabolites are altered in euthymic bipolar I disorder.
Soeiro-de-Souza MG; Henning A; Machado-Vieira R; Moreno RA; Pastorello BF; da Costa Leite C; Vallada H; Otaduy MC
Eur Neuropsychopharmacol; 2015 Dec; 25(12):2221-9. PubMed ID: 26476706
[TBL] [Abstract][Full Text] [Related]
20. Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of
Nakahara T; Tsugawa S; Noda Y; Ueno F; Honda S; Kinjo M; Segawa H; Hondo N; Mori Y; Watanabe H; Nakahara K; Yoshida K; Wada M; Tarumi R; Iwata Y; Plitman E; Moriguchi S; de la Fuente-Sandoval C; Uchida H; Mimura M; Graff-Guerrero A; Nakajima S
Mol Psychiatry; 2022 Jan; 27(1):744-757. PubMed ID: 34584230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
